ROKA Insider Trading Activity and SEC Form 4 Filings
ROKA insider trading summary
No open-market insider purchases or sales of Roka BioScience, Inc. (ROKA) have been reported on SEC Form 4 in the past 12 months.
Latest ROKA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 3, 2017 | Orbimed Advisors LLC | 10% Owner | Sell | $1K (1,899 @ $0.68) |
| Oct 3, 2017 | Orbimed Advisors LLC | 10% Owner | Sell | $136K (199,718 @ $0.68) |
| Oct 3, 2017 | OrbiMed Capital GP III LLC | 10% Owner | Sell | $1K (1,899 @ $0.68) |
| Oct 3, 2017 | Samuel D Isaly | 10% Owner | Sell | $136K (199,718 @ $0.68) |
| Oct 3, 2017 | Samuel D Isaly | 10% Owner | Sell | $1K (1,899 @ $0.68) |
| Oct 3, 2017 | OrbiMed Capital GP III LLC | 10% Owner | Sell | $136K (199,718 @ $0.68) |
| Sep 29, 2017 | Samuel D Isaly | 10% Owner | Sell | $657 (888 @ $0.74) |
| Sep 29, 2017 | Orbimed Advisors LLC | 10% Owner | Sell | $69K (93,246 @ $0.74) |
| Sep 29, 2017 | OrbiMed Capital GP III LLC | 10% Owner | Sell | $69K (93,246 @ $0.74) |
| Sep 29, 2017 | Samuel D Isaly | 10% Owner | Sell | $69K (93,246 @ $0.74) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.